BR0314166A - Teste de hcv - Google Patents

Teste de hcv

Info

Publication number
BR0314166A
BR0314166A BR0314166-7A BR0314166A BR0314166A BR 0314166 A BR0314166 A BR 0314166A BR 0314166 A BR0314166 A BR 0314166A BR 0314166 A BR0314166 A BR 0314166A
Authority
BR
Brazil
Prior art keywords
antigen
hcv
polyprotein
hcv test
assay
Prior art date
Application number
BR0314166-7A
Other languages
English (en)
Other versions
BRPI0314166B1 (pt
BR0314166B8 (pt
Inventor
David Chien
Phillip Arcangel
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of BR0314166A publication Critical patent/BR0314166A/pt
Publication of BRPI0314166B1 publication Critical patent/BRPI0314166B1/pt
Publication of BR0314166B8 publication Critical patent/BR0314166B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Abstract

"TESTE DE HCV". é fornecido um teste de antígeno/anticorpo/antígeno de HCV. O teste utiliza um primeiro antígeno isolado de uma região da poliproteína de HCV e um antígeno de fusão de epítopes múltiplos de HCV que inclui um epítope da mesma região da poliproteína que o primeiro antígeno. Tanto o primeiro antígeno como o antígeno de fusão de epítopes múltiplos aglutinam-se a anticorpos presentes em uma amostra infectada por HCV.
BRPI0314166A 2002-09-09 2003-09-08 teste de hcv BR0314166B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40951502P 2002-09-09 2002-09-09
PCT/US2003/028071 WO2004021871A2 (en) 2002-09-09 2003-09-08 Hcv assay

Publications (3)

Publication Number Publication Date
BR0314166A true BR0314166A (pt) 2005-07-19
BRPI0314166B1 BRPI0314166B1 (pt) 2016-06-14
BR0314166B8 BR0314166B8 (pt) 2021-07-27

Family

ID=31978759

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314166A BR0314166B8 (pt) 2002-09-09 2003-09-08 teste de hcv

Country Status (15)

Country Link
US (1) US7166426B2 (pt)
EP (1) EP1546414B1 (pt)
JP (2) JP4585314B2 (pt)
CN (1) CN1694971B (pt)
AT (1) ATE410693T1 (pt)
AU (1) AU2003273296B2 (pt)
BR (1) BR0314166B8 (pt)
CA (1) CA2498228C (pt)
DE (1) DE60324003D1 (pt)
ES (1) ES2312806T3 (pt)
MX (1) MXPA05002641A (pt)
NO (1) NO337695B1 (pt)
NZ (1) NZ538711A (pt)
PL (1) PL209710B1 (pt)
WO (1) WO2004021871A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2377978T3 (es) * 2004-08-27 2012-04-03 Novartis Vaccines And Diagnostics, Inc. Mutantes de proteínas no estructurales de VHC y usos de los mismos
AU2005295317B2 (en) 2004-10-18 2011-10-13 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
US20080220448A1 (en) * 2006-09-01 2008-09-11 Blincko Stuart J Antigenic protein conjugates and process for preparing same
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
WO2010033841A1 (en) 2008-09-19 2010-03-25 Globeimmune, Inc. Immunotherapy for chronic hepatitis c virus infection
BR112012030808A2 (pt) * 2010-06-02 2016-11-01 Mp Biomedicals Asia Pacific Pte Ltd ensaio de vírus da hepatite c de multilinhagem rápido
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN104697988B (zh) * 2015-02-10 2017-10-03 深圳市新产业生物医学工程股份有限公司 检测丙型肝炎病毒抗体的试剂盒及其检测方法和应用
CN111999496A (zh) * 2020-08-20 2020-11-27 必欧瀚生物技术（合肥）有限公司 一种SARS-CoV-2抗原抗体联合检测的试剂盒及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US6171782B1 (en) * 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
ES2012739T5 (es) 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.
HU225068B1 (en) 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
IE65172B1 (en) * 1989-12-18 1995-10-04 Wellcome Found Viral agent
PL172133B1 (pl) 1990-04-04 1997-08-29 Chiron Corp Sposób tworzenia kombinacji antygenów wirusowego zapalenia watroby typu C (HCV) i sposób wykrywania przeciwcial przeciw wirusowemu zapaleniu watroby typu C (HCV) PL PL PL PL PL PL
US6312889B1 (en) * 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
RO117329B1 (ro) 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) * 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) * 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
CA2250723C (en) 1996-05-24 2012-07-17 Chiron Corporation Multiple epitope fusion protein
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
SI1354204T2 (sl) * 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza

Also Published As

Publication number Publication date
EP1546414A4 (en) 2006-03-08
CN1694971B (zh) 2010-05-26
US7166426B2 (en) 2007-01-23
NZ538711A (en) 2007-01-26
ATE410693T1 (de) 2008-10-15
MXPA05002641A (es) 2005-05-05
PL209710B1 (pl) 2011-10-31
NO20051715L (no) 2005-05-23
BRPI0314166B1 (pt) 2016-06-14
AU2003273296B2 (en) 2009-11-26
WO2004021871A2 (en) 2004-03-18
WO2004021871A3 (en) 2005-02-24
EP1546414A2 (en) 2005-06-29
JP2005538355A (ja) 2005-12-15
JP2009258128A (ja) 2009-11-05
CN1694971A (zh) 2005-11-09
US20040142321A1 (en) 2004-07-22
NO337695B1 (no) 2016-06-06
AU2003273296A1 (en) 2004-03-29
BR0314166B8 (pt) 2021-07-27
PL375600A1 (en) 2005-12-12
DE60324003D1 (en) 2008-11-20
JP4585314B2 (ja) 2010-11-24
CA2498228A1 (en) 2004-03-18
CA2498228C (en) 2011-03-22
ES2312806T3 (es) 2009-03-01
EP1546414B1 (en) 2008-10-08

Similar Documents

Publication Publication Date Title
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
NO20051715L (no) HCV assay
DE60141844D1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
MXPA01012662A (es) Deteccion temprana de flavivirus que utiliza la glicoproteina ns1.
UA39944C2 (uk) Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
HUP0201087A2 (hu) Hepatitisz-C antigén-antitest kombinációs vizsgálati eljárás a fertőzés korai kimutatására
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
DK0599913T3 (da) Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme
TWI256306B (en) Monoclonal antibody hybridoma capable of generating human hepatitis B virus surface antigen (HbsAg), the monoclonal antibody generated from said hybridoma, and a test kit using the same

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US)

Free format text: ALTERADO DE: CHIRON CORPORATION

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B25A Requested transfer of rights approved

Owner name: GRIFOLS WORLDWIDE OPERATIONS LIMITED (IE)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/06/2016, OBSERVADAS AS CONDICOES LEGAIS.

B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/09/2003, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2739 DE 04-07-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.